Leaflet SUPRANE 100% volatile liquid for inhalations


Indicated for: general anesthesia; procedural sedation

Route of administration: inhalation

Substance: desflurane (general anesthetic)

ATC: N01AB07 (Nervous system | Anesthetics, general | Halogenated hydrocarbons)

Desfluranum is an inhaled anesthetic agent used for the induction and maintenance of general anesthesia. It is characterized by rapid onset and quick recovery, making it suitable for short surgical procedures.

The medication is administered through an anesthesia machine and is used under the supervision of an anesthesiologist. It is effective in maintaining an adequate level of anesthesia during surgery.

Side effects may include coughing, nausea, vomiting, hypotension, or, in rare cases, malignant hyperthermia. It is important to inform your doctor about any pre-existing conditions or allergies.

Consult your anesthesiologist to discuss the benefits and risks of using Desfluranum. This medication should only be used in controlled environments such as operating rooms.

General data about SUPRANE 100%

  • Substance: desflurane
  • Date of last drug list: 01-07-2013
  • Commercial code: W43296002
  • Concentration: 100%
  • Pharmaceutical form: volatile liquid for inhalations
  • Packing volume: 240 ml
  • Product type: generic
  • Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.

Marketing authorisation

  • Manufacturer: BAXTER S.A. - BELGIA
  • Holder: BAXTER SA - BELGIA
  • Number: 8048/2015/02
  • Shelf life: 3 years

Pharmaceutical forms available for desflurane